Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William Stevenson

Showing results (71-80 of 112) with videos related to

Pageof 12
Sort By:
Cancer|February 18, 2010
Cause of death in patients with lower-risk myelodysplastic syndromeFarshid Dayyani, Anthony P Conley, Sara S Strom, et al.
Pathology|January 15, 2020
An integrated approach to inherited platelet disorders: results from a research collaborative, the Sydney Platelet GroupDavid Rabbolini, David Connor, Marie-Christine Morel-Kopp, et al.
Journal of Neuroinflammation|April 13, 2017
Effects of environmental enrichment on white matter glial responses in a mouse model of chronic cerebral hypoperfusionYoshiki Hase, Lucinda Craggs, Mai Hase, et al.
Endocrine Oncology (Bristol, England)|April 8, 2026
Therapy-related myeloid neoplasms following peptide receptor radionuclide therapy for neuroendocrine neoplasms: case series reporting characteristics and outcomes from single-centre experienceWallace Chow, Ivy Wen, Claire Mok, et al.
European Journal of Haematology|June 19, 2019
The tumour microenvironment is immuno-tolerogenic and a principal determinant of patient outcome in EBV-positive diffuse large B-cell lymphomaColm Keane, Joshua Tobin, Jay Gunawardana, et al.
British Journal of Haematology|February 16, 2017
Lymphoma cell-of-origin assignment by gene expression profiling is clinically meaningful across broad laboratory contextsGrace Gifford, Sara Gabrielli, Anthony Gill, et al.
Journal of Psychosocial Oncology|December 14, 2019
A multi-center randomized controlled trial to reduce unmet needs, depression, and anxiety among hematological cancer patients and their support personsWilliam Stevenson, Jamie Bryant, Rochelle Watson, et al.
Pathology|January 24, 2026
Measurable Residual Disease detection in Acute Lymphoblastic Leukaemia - comparison between targeted NGS and ASO-RQPCRJared Lane, Royston Ponraj, Jad Othman, et al.
Ejhaem|July 18, 2022
Second primary malignancies in chronic lymphocytic leukaemia: Skin, solid organ, haematological and Richter's syndromeYandong Shen, Luke Coyle, Ian Kerridge, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|December 20, 2020
Cytomegalovirus (CMV) management in allogeneic hematopoietic cell transplantation: Pre-transplant predictors of survival, reactivation, and spontaneous clearanceJulian Lindsay, Jad Othman, Ian Kerridge, et al.
Pageof 12

Showing results (71-80 of 112) with videos related to

Sort By:
Pageof 12
Cancer|February 18, 2010
Cause of death in patients with lower-risk myelodysplastic syndromeFarshid Dayyani, Anthony P Conley, Sara S Strom, et al.
Pathology|January 15, 2020
An integrated approach to inherited platelet disorders: results from a research collaborative, the Sydney Platelet GroupDavid Rabbolini, David Connor, Marie-Christine Morel-Kopp, et al.
Journal of Neuroinflammation|April 13, 2017
Effects of environmental enrichment on white matter glial responses in a mouse model of chronic cerebral hypoperfusionYoshiki Hase, Lucinda Craggs, Mai Hase, et al.
Endocrine Oncology (Bristol, England)|April 8, 2026
Therapy-related myeloid neoplasms following peptide receptor radionuclide therapy for neuroendocrine neoplasms: case series reporting characteristics and outcomes from single-centre experienceWallace Chow, Ivy Wen, Claire Mok, et al.
European Journal of Haematology|June 19, 2019
The tumour microenvironment is immuno-tolerogenic and a principal determinant of patient outcome in EBV-positive diffuse large B-cell lymphomaColm Keane, Joshua Tobin, Jay Gunawardana, et al.
British Journal of Haematology|February 16, 2017
Lymphoma cell-of-origin assignment by gene expression profiling is clinically meaningful across broad laboratory contextsGrace Gifford, Sara Gabrielli, Anthony Gill, et al.
Journal of Psychosocial Oncology|December 14, 2019
A multi-center randomized controlled trial to reduce unmet needs, depression, and anxiety among hematological cancer patients and their support personsWilliam Stevenson, Jamie Bryant, Rochelle Watson, et al.
Pathology|January 24, 2026
Measurable Residual Disease detection in Acute Lymphoblastic Leukaemia - comparison between targeted NGS and ASO-RQPCRJared Lane, Royston Ponraj, Jad Othman, et al.
Ejhaem|July 18, 2022
Second primary malignancies in chronic lymphocytic leukaemia: Skin, solid organ, haematological and Richter's syndromeYandong Shen, Luke Coyle, Ian Kerridge, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|December 20, 2020
Cytomegalovirus (CMV) management in allogeneic hematopoietic cell transplantation: Pre-transplant predictors of survival, reactivation, and spontaneous clearanceJulian Lindsay, Jad Othman, Ian Kerridge, et al.
Pageof 12